Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By Cancer

NCT ID: NCT00313573

Last Updated: 2013-09-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

480 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Telemedicine may help in the treatment of depression and/or pain caused by cancer. It is not yet known whether telemedicine is more effective than standard care in treating depression and/or pain caused by cancer.

PURPOSE: This phase III randomized clinical trial is studying telemedicine to see how well it works compared to standard care in treating patients with depression and/or pain caused by cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

Primary

* Compare the effectiveness of a state-wide, telemedicine intervention with standard care in cancer patients with clinical depression and/or cancer-related pain.
* Compare improvement in clinical depression and/or cancer-related pain in patients undergoing these interventions.

Secondary

* Compare health-related quality of life, functional status, and patient satisfaction with treatment in patients undergoing these interventions.
* Compare the economic benefits of these interventions in these patients.

OUTLINE: This is a randomized, longitudinal, multicenter study. Patients are stratified according to study site and type of symptom (pain only vs depression only vs pain and depression). Patients are randomized to 1 of 2 treatment arms.

* Arm I (standard care): Patients receive treatment for pain, depression, and other symptoms from their oncologist.
* Arm II (telemedicine intervention): Patients undergo automated, home-based symptom monitoring either by telephone or the Internet, depending on preference, coupled with telephonic care management by a clinical specialist. Patients complete questionnaires via the Internet or undergo standardized interviews via telephone measuring depression, pain, quality of life, and other patient-reported variables twice weekly for approximately 1 month, once weekly for 2 months, twice a month for 3 months, and then once a month for 6 months. A clinical specialist trained in treating the symptoms of pain and depression also contacts the patient by phone to assess symptom severity and initiate treatment. A follow-up call is made at 1-2 weeks to assess symptom severity, adherence, and adverse effects. Patients with depression receive 2 additional follow-up calls in the first 12 weeks. The clinical specialist also calls the patient when automated monitoring indicates inadequate symptom improvement or side effects, or the patient requests to be contacted. The clinical specialist works with the patient's regular doctor in adjusting medicines and treatment for symptoms as needed. Patients who do not complete their scheduled assessments receive an automated call or e-mail message reminding them to complete the symptoms questionnaires. Patients who do not respond to this reminder within 24 hours are contacted by the clinical specialist.

In both arms, patients are interviewed at baseline, 1, 3, 6, and 12 months. Patients are asked questions about pain, depression, other physical and emotional symptoms, work activities, quality of life, and satisfaction with treatment.

PROJECTED ACCRUAL: A total of 480 patients will be accrued for this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Pain Unspecified Adult Solid Tumor, Protocol Specific

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

unspecified adult solid tumor, protocol specific pain depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

management of therapy complications

Intervention Type PROCEDURE

pain therapy

Intervention Type PROCEDURE

psychosocial assessment and care

Intervention Type PROCEDURE

quality-of-life assessment

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

PATIENT CHARACTERISTICS:

* Life expectancy ≥ 6 months
* Must speak English
* Not pregnant
* Fertile patients must use effective contraception
* No moderately severe cognitive impairment
* No schizophrenia or other psychosis
* No disability claim currently being adjudicated for pain

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics
* Not in hospice care
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Indiana University Melvin and Bren Simon Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Regenstrief Institute, Incorporated

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kurt Kroenke, MD

Role: STUDY_CHAIR

Regenstrief Institute, Incorporated

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Community Cancer Center at Community Hospital of Anderson

Anderson, Indiana, United States

Site Status

Community Cancer Care at Bedford Oncology Specialty Clinic

Bedford, Indiana, United States

Site Status

Columbus Regional Hospital Cancer Center

Columbus, Indiana, United States

Site Status

Community Cancer Care at Putnam County Hospital

Greencastle, Indiana, United States

Site Status

Community Cancer Care at Decatur County Hospital

Greensburg, Indiana, United States

Site Status

Regenstrief Institute, Incorporated

Indianapolis, Indiana, United States

Site Status

Community Cancer Care

Indianapolis, Indiana, United States

Site Status

Veterans Affairs Medical Center - Indianapolis

Indianapolis, Indiana, United States

Site Status

William N. Wishard Memorial Hospital

Indianapolis, Indiana, United States

Site Status

Methodist Cancer Center at Methodist Hospital

Indianapolis, Indiana, United States

Site Status

Community Regional Cancer Care at Community Hospital East

Indianapolis, Indiana, United States

Site Status

Community Regional Cancer Care at Community Hospital North

Indianapolis, Indiana, United States

Site Status

Community Cancer Care at Howard Regional Health System

Kokomo, Indiana, United States

Site Status

Community Cancer Care at King's Daughters' Hospital

Madison, Indiana, United States

Site Status

Schneck Medical Center

Seymour, Indiana, United States

Site Status

Community Cancer Care at Perry County Hospital

Tell City, Indiana, United States

Site Status

Community Cancer Care at Tipton County Memorial Hospital

Tipton, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psychooncology. 2010 Jul;19(7):734-41. doi: 10.1002/pon.1627.

Reference Type RESULT
PMID: 19777535 (View on PubMed)

Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter J, Tu W. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA. 2010 Jul 14;304(2):163-71. doi: 10.1001/jama.2010.944.

Reference Type RESULT
PMID: 20628129 (View on PubMed)

Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS. Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med. 2010 Oct 11;170(18):1686-94. doi: 10.1001/archinternmed.2010.337.

Reference Type RESULT
PMID: 20937930 (View on PubMed)

Cohee AA, Kroenke K, Vachon E, Wu J, Tu W, Johns SA. Predictors of depression outcomes in adults with cancer: A 12 month longitudinal study. J Psychosom Res. 2020 Sep;136:110169. doi: 10.1016/j.jpsychores.2020.110169. Epub 2020 Jun 11.

Reference Type DERIVED
PMID: 32559503 (View on PubMed)

Kroenke K, Wu J, Yu Z, Bair MJ, Kean J, Stump T, Monahan PO. Patient Health Questionnaire Anxiety and Depression Scale: Initial Validation in Three Clinical Trials. Psychosom Med. 2016 Jul-Aug;78(6):716-27. doi: 10.1097/PSY.0000000000000322.

Reference Type DERIVED
PMID: 27187854 (View on PubMed)

Choi Yoo SJ, Nyman JA, Cheville AL, Kroenke K. Cost effectiveness of telecare management for pain and depression in patients with cancer: results from a randomized trial. Gen Hosp Psychiatry. 2014 Nov-Dec;36(6):599-606. doi: 10.1016/j.genhosppsych.2014.07.004. Epub 2014 Jul 19.

Reference Type DERIVED
PMID: 25130518 (View on PubMed)

Hayano J, Carney RM, Watanabe E, Kawai K, Kodama I, Stein PK, Watkins LL, Freedland KE, Blumenthal JA. Interactive associations of depression and sleep apnea with adverse clinical outcomes after acute myocardial infarction. Psychosom Med. 2012 Oct;74(8):832-9. doi: 10.1097/PSY.0b013e31826d2c81. Epub 2012 Sep 28.

Reference Type DERIVED
PMID: 23023681 (View on PubMed)

Wang HL, Kroenke K, Wu J, Tu W, Theobald D, Rawl SM. Predictors of cancer-related pain improvement over time. Psychosom Med. 2012 Jul-Aug;74(6):642-7. doi: 10.1097/PSY.0b013e3182590904. Epub 2012 Jun 28.

Reference Type DERIVED
PMID: 22753637 (View on PubMed)

Dube P, Kurt K, Bair MJ, Theobald D, Williams LS. The p4 screener: evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patients. Prim Care Companion J Clin Psychiatry. 2010;12(6):PCC.10m00978. doi: 10.4088/PCC.10m00978blu.

Reference Type DERIVED
PMID: 21494337 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IUMC-051009

Identifier Type: -

Identifier Source: secondary_id

CDR0000466348

Identifier Type: -

Identifier Source: org_study_id